Navigation Links
Penn researchers find potential in yeast for selecting Lou Gehrig's disease drugs
Date:4/17/2008

PHILADELPHIA - Researchers from the University of Pennsylvania School of Medicine are developing a novel approach to screen for drugs to combat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, using yeast cells. In recent months a number of mutations have been found in a disease protein called TDP-43, which is implicated in ALS and certain types of frontotemporal dementia (FTD).

We've created a yeast model, the same cells that bakers and brewers use to make bread and beer, to express TDP-43, explains lead author Aaron D. Gitler, PhD, Assistant Professor of Cell and Developmental Biology. Remarkably, this protein formed clumps in our simple yeast cells just like it does in human nerve cells. In our paper we determine which segments of the mutated TDP-43 protein cause it to aggregate and which parts cause it to be toxic. Gitler and colleagues report their findings in this weeks advance online issue of the Proceedings of the National Academy of Sciences.

Two years ago, other Penn investigators found that TDP-43 accumulated abnormally in post-mortem brain or nervous system tissue from individuals diagnosed with either ALS or FTD. TDP-43 is normally involved in RNA and DNA processing, among other cellular tasks. The recent TDP-43 mutation studies confirm the proteins role in causing disease.

The clumping process of proteins takes decades in humans but the researchers could model the process within a matter of hours in yeast cells. This now allows for rapid genetic screening to identify proteins that can reverse the harmful effects of the disease protein; visualizing the clumping; and testing molecules that could eliminate or prevent clumping.

Our yeast model will be a powerful tool for performing large-scale drug screens to look for small molecules that can prevent TDP-43 from aggregating or that can protect cells from aggregated TDP-43, notes Gitler.

Normally, TDP-43 sta
'/>"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. MU researchers find clue to cataract formation
2. Researchers evaluating food allergy treatment
3. U of M researchers identify process that may help treat Parkinsons, spinal cord injuries
4. OHSU Cancer Institute researchers discover key gene involvement in cancer development
5. Combining liver cancer treatments doubles survival rates, UVA researchers find
6. Leading HIV researchers to collaborate on vaccine development
7. Georgetown researchers find stem cell marker controls 2 key cancer pathways
8. Blood pressure drugs halt pancreatic cancer cell growth, Jefferson researchers find
9. OHSU Cancer Institute researchers find connection between protein, prognosis in breast cancer
10. Karmanos Researchers Report Enhanced Chemosensitivity of Pancreatic Cancer Cells by Black Seed Component
11. Penn researchers find targeted therapy combination overcomes treatment resistance in liver cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , NEW YORK, Nov. 30 Of the mo...o are living with HIV/AIDS, nearly half are Africa... in Washington, D.C. have surpassed the threshold ...omen account for more than 90 percent of all women...On Tuesday, December 1 at 6:00 p.m.*, World AIDS D...
(Date:11/30/2009)... tiny period of time between the registration of a...onscious recognition of it ― between the tim...an apple. Our minds lag behind our eyes, but by ho...the world around us? , Some estimates say the ... 500 milliseconds. A new study by Tel Aviv Univers...
(Date:11/30/2009)... Keynote speaker & Author Dr. Tem... Corpus Christi, TX (Vocus) Nov...onference is set to be held in Corpus Christi fro...5, 2009 at the American Bank Center., , , , ,The ...ted to make a nearly $300,000 economic impact on t...
(Date:11/30/2009)... , NEW YORK, Nov. 30 Reportlink... is available in its catalogue: ,, Key Players...ing strategies in ingredients, pharma, food and dr...Key-Players-and-Innovative-Start-Ups-in-Nutraceuti...d-and-drinks.html ,, Nutraceuticals are bioact...
(Date:11/30/2009)...ASHINGTON, Nov. 30 - Salon Leau ann...n Monday, December 7(th) to raise funds and create...rminal diseases. All proceeds from each haircut an...Research Hospital. ,, Salon Leau has been serv...lon is owned by LoAnn Lai, widely recognized for h...
Breaking Medicine News(10 mins):Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 2Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 3Health News:Now you see it, now you know you see it 2Health News:18th Annual Texas Autism Conference Returns To Corpus Christi, Makes Nearly $300,000 Economic Impact 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 3Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 4Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 6Health News:Georgetown Hair Salon Helps St. Jude Find A Cure 2
...y Institute Announces Results of Milken ...an Be Avoided with Proper Treatment and Prevention...UNSWICK, N.J., July 29 In a groundbreaking study,...on. In the U.S. as a whole, the cost is a staggeri...
...y, August 1, 2008 at 10 AM, WELLINGTON, Fla., Jul....QuantumMD.com ) has announced that pursuant to th...Caridad Center, Palm Beach,County,s largest free c...ntum Annual Shareholder Meeting in Orlando,Florida...
...ternists and pediatricians in the United States ar...s for young adults with complex chronic illnesses ...ings from a new national survey. , The survey, co...tricians to assess their comfort levels in treatin...
...s get people moving, study finds , , TUESD...riendly neighborhoods can help keep waistlines tri...find that two easily available census measures of ...esearcher Barbara Brown, a professor of family and...
...Take Medicines Safely, WASHINGTON, July 29 The N...ug Administration to issue a guidance for a,combin...receive their,prescription drugs. In a petition fi...unity Pharmacists,Association, the National Allian...
... a mark on the brain, by changing patterns of brai...ep and problems with attention. For one in six Ame...y bladder contractions that often trigger more fre...ee how an abnormal organ affects the whole organis...
Other Medicine News:Health News:Annual Economic Impact of Chronic Disease on New Jersey Economy Is $39 Billion 2Health News:Annual Economic Impact of Chronic Disease on New Jersey Economy Is $39 Billion 3Health News:Annual Economic Impact of Chronic Disease on New Jersey Economy Is $39 Billion 4Health News:The Quantum Group Announces Exclusive Screening of New PWeR(TM) System 2Health News:The Quantum Group Announces Exclusive Screening of New PWeR(TM) System 3Health News:Most generalists reluctant to provide primary care for young adults with chronic illness 2Health News:Most generalists reluctant to provide primary care for young adults with chronic illness 3Health News:Walkable Neighborhoods Keep the Pounds Off 2Health News:Consumer and Healthcare Groups Call for Clear, Concise Single Document From Pharmacy 2Health News:Findings on bladder-brain link may point to better treatments for problems in sleep, attention 2
(Date:11/30/2009)..., BLOOMFIELD HILLS, Mich., Nov. 30 /PRNewswire/...opping site dedicated exclusively to products appr...gs Account (FSA/HSA) claims. The site is also the...counter medications, saving shoppers up to 75 perc...ource helps cure two common healthcare headaches -...
(Date:11/30/2009)... , BOZEN, Italy, November 30 /PRNewswire/...nveil TPNstation,s development plans and product s... "Totally Automated Parenteral,Nutrition", a new k... to be,showcased at Las Vegas, ASHP (Booth # 114)....om our customers to the,TPNstation,s blueprints an...
(Date:11/30/2009)... , TEL AVIV, Israel, November 30 /PRNewsw...f the FOMRI-III(TM) dual channel microphone, the m...in functional magnetic resonance imaging,(fMRI) en...represents a major step forward for fiber,optic mi... quality ever, with,low-latency adaptive noise can...
Breaking Medicine Technology:eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 3New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2Best Lawyers in America Selects Three Attorneys from Boston Law Firm Lubin 26amp 3B Meyer 58499 1Best Lawyers in America Selects Three Attorneys from Boston Law Firm Lubin 26amp 3B Meyer 58499 2Best Lawyers in America Selects Three Attorneys from Boston Law Firm Lubin 26amp 3B Meyer 58499 3Superior Efficacy dose Ratio for Lantus 28R 29 Over detemir 14287 1Superior Efficacy dose Ratio for Lantus 28R 29 Over detemir 14287 2Superior Efficacy dose Ratio for Lantus 28R 29 Over detemir 14287 3Superior Efficacy dose Ratio for Lantus 28R 29 Over detemir 14287 4Superior Efficacy dose Ratio for Lantus 28R 29 Over detemir 14287 5Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 1Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 2Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 3Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 4Resverlogix RVX 208 Second Clinical Trial Demonstrates Success on Key Reverse Cholesterol Transport Markers 14285 5
...ANCISCO, Calif., May 28 Sunesis,Pharmaceuticals, ...ng,clinical trials of voreloxin (formerly SNS-595)...ated interim data from Sunesis, ongoing Phase 2 cl...arian cancer patients will be presented,during the... Annual Meeting,being held May 30 - June 3, 2008 i...
...R) for hepatitis C and LymphoStat-B(R) for lupus o... in 2010 -,- ABthrax(TM) for inhalation anthrax on... strengthened with investments in oncology portfol...tive - - GSK to advance darapladib to Phase 3...uman Genome Sciences,Inc. (Nasdaq: HGSI ) today w...
Other Medicine Technology:Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress 2Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress 3Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 2Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 3Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 4Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 5Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 6Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 7Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 8Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 9Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 10Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives 11
DataMate Mother/Father/Infant Laser Wristbands
DataMate Laser Label/Wristband Sheet
PrimeBand® Wristbands
Securline® Bar Code Band Wristbands
Medicine Products: